GlaxoSmithKline | Spese Operative

Prezzo Delle Azioni
2,187.50
Cambio Giornaliero
7.50 0.34%
Mensile
15.04%
Annuale
51.59%
Q1 Previsione
1,839.16




Spese Operative Cambiamento Data
AbbVie USD 10.81B 13.45B 2025-12
Alcon AG USD 2.28B 67M 2025-09
Almirall EUR 517.43M 43.18M 2025-06
Amgen USD 5.9B 773M 2025-12
argenx SE USD 776.99M 32.87M 2025-09
AstraZeneca USD 16.69B 5.74B 2025-09
Bayer EUR 10.2B 523M 2025-09
Biogen USD 1.88B 81.4M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Fresenius EUR 4.91B 110M 2025-09
Fresenius Medical Care EUR 4.43B 73.91M 2025-09
Galapagos EUR 112.83M 9.48M 2025-09
Genmab DKK 565M 38M 2025-06
Gilead Sciences USD 4.26B 95M 2025-09
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Glaxosmithkline GBP 7.77B 2.22B 2025-09
GRIFOLS EUR 1.51B 28.3M 2025-09
Hikma Pharmaceutical USD 642M 663M 2025-06
Lonza CHF 3.09B 564M 2024-12
Merck EUR 4.11B 117M 2025-09
Merck USD 10.16B 558M 2025-12
Novartis USD 9.86B 115M 2025-09
Novo Nordisk DKK 46.76B 3.99B 2025-12
Orion EUR 302.2M 9.7M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Philips EUR 3.97B 123M 2025-09
Recordati EUR 466.68M 27.25M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sanofi EUR 10.51B 1.21B 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
UCB EUR 2.36B 108M 2024-12


GlaxoSmithKline Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.